A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19.

A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19. Abstract Text:

A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19. Publishing Authors By Initials

For similar biological sciences: physiology research abstracts see: biological sciences: physiology research

PUBMED ID PMID:

MEDLINE DATE:

A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: [Report]. Civil Aeromedical Research Institute (U.

VOLUME: 26

Page Numbers: 1-6

Journal Abbreviation:

ISSN:

DAY: 3

MONTH: Sep

YEAR: 1963

A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 75005

A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19. Keywords Mesh Terms:

KEYWORDS: Physiology

MESH TERMS:

Chemical & Substance for Abstract: A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE. REP 63-19.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Rep Civ Aeromed Res Inst US

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A CENTRAL FACTOR IN PURE TONE AUDITORY FATIGUE REP 63-19 Related Publications

• 15. Reactions of calf thymus DNA with the electrophiles methylmercury(ii) nitrate, cis-dichlorodiammineplatinum(ii), and trans-dichlorodiammineplatinum(ii) studied using raman difference spectroscopy Evidence for the formation of c-DNA upon metalation.
• Acute subacute bacterial endocarditis.
• An unusual presacral tumor.
• An unusual presacral tumor.
• Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors.
• Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer : What is the Optimal Initiation Time for the Maximum Benefit?
• Bone fragility contributes to the risk of fracture in children, even after moderate and severe trauma.
• Cardiovascular device infections in dogs: report of 8 cases and review of the literature.
• Chancres of the tongue.
• Combined general and spinal anesthesia in an infant with single-ventricle physiology undergoing anorectoplasty for an imperforate anus.
• Diffraction-based density restraints for membrane and membrane-peptide molecular dynamics simulations.
• Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
• Hydroxyl radical at the air-water interface.
• Impaired growth plate function in bmp-6 null mice.
• Increased bone morphogenetic protein-6 expression in mouse long bones after estrogen administration.
• Intentional use of intra-arterial medications when venous access is not available.
• Methyl group dynamics as a probe of the protein dynamical transition.
• Minimally invasive per-catheter patent ductus arteriosus occlusion in dogs using a prototype duct occluder.
• Neoplastic cell transformation by heavy charged particles.
• Optimal experimental design in chromatography.
• Perioperative care of the patient with osteogenesis imperfecta.
• Pro: dexmedetomidine should be used for infants and children undergoing cardiac surgery.
• Resuscitation apparatus. No. 2,453,475.
• TLRs in disease.
• The Amplatz canine duct occluder: a novel device for patent ductus arteriosus occlusion.
• The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
• The repair-misrepair model in radiobiology: comparison to other models.
• The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.
• Tickbite granuloma.
• [Not Available.]